MedTrace Logo

Treatment Strategy for Rectal Cancer Patients With Complete Clinical Response

NCT03846726 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 513

Last updated 2023-04-14

No results posted yet for this study

Summary

This was a propensity-score matched observational analysis, comparing the oncological outcome of surgical resection vs watch and wait apporach for rectal cancer patients with a cCR.

Conditions

Interventions

PROCEDURE

standard TME surgery

radical resection for rectal cancer

Sponsors & Collaborators

  • Sixth Affiliated Hospital, Sun Yat-sen University

    collaborator OTHER

  • Peking University Cancer Hospital & Institute

    collaborator OTHER

  • Second Affiliated Hospital, School of Medicine, Zhejiang University

    collaborator OTHER

  • Fujian Medical University Union Hospital

    collaborator OTHER

  • Fujian Cancer Hospital

    collaborator OTHER_GOV

  • Tongji Hospital

    collaborator OTHER

  • Yuan-hong Gao

    lead OTHER

Principal Investigators

  • Yuan-hong Gao, MD · Sun Yat-sen University

Eligibility

Min Age
16 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-01-01
Primary Completion
2019-02-28
Completion
2019-02-28

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03846726 on ClinicalTrials.gov